Yang Liu

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao-Dan Lyu, Yang Liu, Jia Wang, Yuan-Cheng Wei, Yi Han, Xue Li, Qian Zhang, Zheng-Rui Liu, Zheng-Zheng Li, Jing-Wei Jiang, Hao-Lin Hu, Sheng-Tao Yuan, Li Sun
A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer. Cancers 15 (20) (2023)
Si-Yuan Jiang, Tian Tian, Wen-Jie Li, Ting Liu, Cong Wang, Gang Hu, Ren-Hong Du, Yang Liu, Ming Lu
Mefloquine targets NLRP3 to reduce lipopolysaccharide-induced systemic inflammation and neural injury. EMBO reports (2023)

Yang Liu.css-eqlu8i{font-size:small;padding-left:4px;}